KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in Net LoansDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Gains from Sales and Divestitures (2016 - 2025)

Historic Gains from Sales and Divestitures for Omega Healthcare Investors (OHI) over the last 16 years, with Q4 2025 value amounting to $1.6 million.

  • Omega Healthcare Investors' Gains from Sales and Divestitures rose 17808.6% to $1.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 million, marking a year-over-year increase of 17808.6%. This contributed to the annual value of $1.6 million for FY2025, which is 17808.6% up from last year.
  • As of Q4 2025, Omega Healthcare Investors' Gains from Sales and Divestitures stood at $1.6 million, which was up 17808.6% from $578763.0 recorded in Q4 2024.
  • In the past 5 years, Omega Healthcare Investors' Gains from Sales and Divestitures ranged from a high of $1.6 million in Q4 2025 and a low of $165206.0 during Q4 2022
  • For the 5-year period, Omega Healthcare Investors' Gains from Sales and Divestitures averaged around $761868.4, with its median value being $578763.0 (2024).
  • As far as peak fluctuations go, Omega Healthcare Investors' Gains from Sales and Divestitures plummeted by 8302.34% in 2022, and later soared by 19222.43% in 2023.
  • Quarter analysis of 5 years shows Omega Healthcare Investors' Gains from Sales and Divestitures stood at $973142.0 in 2021, then plummeted by 83.02% to $165206.0 in 2022, then soared by 192.22% to $482772.0 in 2023, then rose by 19.88% to $578763.0 in 2024, then surged by 178.09% to $1.6 million in 2025.
  • Its Gains from Sales and Divestitures was $1.6 million in Q4 2025, compared to $578763.0 in Q4 2024 and $482772.0 in Q4 2023.